Related references
Note: Only part of the references are listed.DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis
Arun Thiruvalluvan et al.
MOLECULAR CELL (2020)
Astrocytic expression of the chaperone DNAJB6 results in non-cell autonomous protection in Huntington's disease
Matteo Bason et al.
NEUROBIOLOGY OF DISEASE (2019)
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
Mathilde Mathieu et al.
NATURE CELL BIOLOGY (2019)
Conserved S/T Residues of the Human Chaperone DNAJB6 Are Required for Effective Inhibition of Aβ42 Amyloid Fibril Formation
Cecilia Mansson et al.
BIOCHEMISTRY (2018)
Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers
Servio H. Ramirez et al.
FLUIDS AND BARRIERS OF THE CNS (2018)
Engineered Exosomes as Vehicles for Biologically Active Proteins
Ulrich Sterzenbach et al.
MOLECULAR THERAPY (2017)
Lipids in exosomes: Current knowledge and the way forward
Tore Skotland et al.
PROGRESS IN LIPID RESEARCH (2017)
Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch
E. F. E. Kuiper et al.
Frontiers in Neuroscience (2017)
Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
Toshihide Takeuchi et al.
BRAIN SCIENCES (2017)
Disease-modifying effects of ganglioside GM1 in Huntington's disease models
Melanie Alpaugh et al.
EMBO MOLECULAR MEDICINE (2017)
Exosome-Based Delivery of miR-124 in a Huntington's Disease Model
Soon-Tae Lee et al.
JOURNAL OF MOVEMENT DISORDERS (2017)
Cellular Engineering with Membrane Fusogenic Liposomes to Produce Functionalized Extracellular Vesicles
Junsung Lee et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
Mercedes Tkach et al.
CELL (2016)
The S/T-Rich Motif in the DNAJB6 Chaperone Delays Polyglutamine Aggregation and the Onset of Disease in a Mouse Model
Vaishali Kakkar et al.
MOLECULAR CELL (2016)
In vivo aspects of protein folding and quality control
David Balchin et al.
SCIENCE (2016)
Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer
Erhong Meng et al.
ONCOTARGET (2016)
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
Dinh Ha et al.
ACTA PHARMACEUTICA SINICA B (2016)
Engineering hybrid exosomes by membrane fusion with liposomes
Yuko T. Sato et al.
SCIENTIFIC REPORTS (2016)
In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior
Anoek Zomer et al.
CELL (2015)
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice
Marta Valenza et al.
EMBO MOLECULAR MEDICINE (2015)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Intercellular chaperone transmission via exosomes contributes to maintenance of protein homeostasis at the organismal level
Toshihide Takeuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes
Ikuhiko Nakase et al.
SCIENTIFIC REPORTS (2015)
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
Oscar P. B. Wiklander et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Interaction of the Molecular Chaperone DNAJB6 with Growing Arnyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation
Cecilia Mansson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The cis-acting signals that target proteins to exosomes and microvesicles
Jr-Ming Yang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders
Anja Schneider et al.
CELL AND TISSUE RESEARCH (2013)
Suppression of protein aggregation by chaperone modification of high molecular weight complexes
John Labbadia et al.
BRAIN (2012)
Protein Targeting to Exosomes/Microvesicles by Plasma Membrane Anchors
Beiyi Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
A DNAJB Chaperone Subfamily with HDAC-Dependent Activities Suppresses Toxic Protein Aggregation
Jurre Hageman et al.
MOLECULAR CELL (2010)
Mouse models of Huntington's disease and methodological considerations for therapeutic trials
Robert J. Ferrante
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Adapting proteostasis for disease intervention
William E. Balch et al.
SCIENCE (2008)
Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease
J. L. Howarth et al.
MOLECULAR THERAPY (2007)
Monomeric red fluorescent protein variants used for imaging studies in different species
Annette Mueller-Taubenberger et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2006)
The Yin and Yang of protein folding
TR Jahn et al.
FEBS JOURNAL (2005)
Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice
A Dedeoglu et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Exosomes:: Composition, biogenesis and function
C Théry et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Share Paper
